Schedule 13G ownership disclosure

Sun BioPharma, Inc.

Security class unavailable

Event date: 2019-08-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001437749-19-017552
Form type
SC 13G/A
Filer
Ryan R. Gilbertson 2012 Irrevocable Trust
CIK
CIK 1652966
Filed
Aug 28, 2019
Reporting period
Aug 16, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub